Utilizing an acute hyperthermia-induced seizure test and pharmacokinetic studies to establish optimal dosing regimens in a mouse model of Dravet syndrome Publication Utilizing an acute hyperthermia-induced seizure test and pharmacokinetic studies to establish optimal dosing regimens in a mouse model of Dravet syndrome Learn how triple‑drug combinations increase clobazam metabolite exposure and improve seizure control, modelled using Phoenix…CertaraAugust 30, 2024
In Vivo Activity of Intestinal P-Glycoprotein and Hepatic Organic Anion Transporters Polypeptide in Pregnancy and Postpartum Publication In Vivo Activity of Intestinal P-Glycoprotein and Hepatic Organic Anion Transporters Polypeptide in Pregnancy and Postpartum Find out how rosuvastatin exposure increases during pregnancy due to reduced OATP activity, while P‑gp…CertaraAugust 27, 2024
Resmetirom: A pioneering NASH clinical program Blog Resmetirom: A pioneering NASH clinical program Nonalcoholic fatty liver disease (NAFLD) is a condition wherein the liver stores excess fat. Nonalcoholic…CertaraAugust 23, 2024
Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization On-Demand Webinar Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization The FDA’s Project Optimus initiative aims to reform dose optimization and selection for oncology therapies…CertaraAugust 19, 2024
Medicines that matter: Biohaven’s Nurtec™ drug development journey Case Study Medicines that matter: Biohaven’s Nurtec™ drug development journey In February 2020, Biohaven Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved…CertaraAugust 15, 2024
Comparative pharmacokinetics of a single oral dose of meloxicam in the California sea lion (Zalophus californianus) and Pacific harbor seal (Phoca vitulina richardii) Publication Comparative pharmacokinetics of a single oral dose of meloxicam in the California sea lion (Zalophus californianus) and Pacific harbor seal (Phoca vitulina richardii) Explore how both pinniped species show long meloxicam half‑lives, suggesting dosing interval reconsideration, modelled using…CertaraJuly 14, 2024
Effect of Nutrition on Drug-Induced Liver Injury: Insights from a High-Fat Diet Mouse Model Publication Effect of Nutrition on Drug-Induced Liver Injury: Insights from a High-Fat Diet Mouse Model Discover how high‑fat diet reduces acetaminophen liver injury and increases clearance in mice, analysed using…CertaraJuly 12, 2024
Comparative pharmacokinetics of phenylbutazone in healthy young-adult and geriatric horses Publication Comparative pharmacokinetics of phenylbutazone in healthy young-adult and geriatric horses See how young and geriatric horses show similar phenylbutazone PK profiles, indicating no dose adjustment…CertaraJune 28, 2024
Ziprasidone population pharmacokinetics and co‑medication effects in Chinese patients Publication Ziprasidone population pharmacokinetics and co‑medication effects in Chinese patients Learn how lorazepam and valproate significantly affect ziprasidone clearance; PopPK modelling supports personalized dosing using…CertaraJune 25, 2024